Payment overview · 2025
General Payments
$114.08
4 reported records · 4 companies
Healthcare provider profile · identity verified
Matthew L Wright, DO
Allopathic & Osteopathic Physicians|Internal Medicine · BEAVER, PA · NPI 1770505174
Verified facts
What the public records show
CMS Open Payments records show Matthew L Wright, DO received $114.08 in general payments during 2025 across 4 reported records.
Baxter Healthcare accounted for 53.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Paxlovid.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 197 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Baxter Healthcare | Unresolved — no canonical attribution shown | $60.77 | 53.3% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $21.87 | 19.2% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $15.74 | 13.8% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $15.70 | 13.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Debt forgiveness | $60.77 | 1 |
| Food and Beverage | $53.31 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $21.87 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $15.74 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $15.74 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $15.70 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| PAXLOVID paxlovid |
2025 | Paxlovid | 2024 | 18 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
197 | 48 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
18 | 18 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 883 | 236 |
| Lisinopril | Lisinopril | 666 | 180 |
| Amlodipine Besylate | Amlodipine Besylate | 548 | 154 |
| Levothyroxine Sodium | Levothyroxine Sodium | 540 | 132 |
| Omeprazole | Omeprazole | 522 | 137 |
| Pantoprazole Sodium | Pantoprazole Sodium | 417 | 116 |
| Furosemide | Furosemide | 346 | 92 |
| Gabapentin | Gabapentin | 328 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 296 | 86 |
| Potassium Chloride | Potassium Chloride | 268 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 262 | 70 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 258 | 75 |
| Metformin Hcl | Metformin Hcl | 251 | 70 |
| Trazodone Hcl | Trazodone Hcl | 242 | 67 |
| Metoprolol Tartrate | Metoprolol Tartrate | 238 | 68 |
| Simvastatin | Simvastatin | 217 | 57 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 210 | 44 |
| Prednisone | Prednisone | 208 | 135 |
| Eliquis | Apixaban | 197 | 48 |
| Jardiance | Empagliflozin | 194 | 43 |
| Irbesartan | Irbesartan | 191 | 54 |
| Diclofenac Sodium | Diclofenac Sodium | 190 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 179 | 58 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 177 | 177 |
| Escitalopram Oxalate | Escitalopram Oxalate | 177 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 176 | 52 |
| Montelukast Sodium | Montelukast Sodium | 174 | 43 |
| Glipizide | Glipizide | 170 | 54 |
| Lorazepam | Lorazepam | 161 | 52 |
| Carvedilol | Carvedilol | 154 | 46 |
| Atenolol | Atenolol | 147 | 40 |
| Pravastatin Sodium | Pravastatin Sodium | 144 | 43 |
| Losartan Potassium | Losartan Potassium | 138 | 40 |
| Alprazolam | Alprazolam | 134 | 27 |
| Synthroid | Levothyroxine Sodium | 126 | 30 |
| Tramadol Hcl | Tramadol Hcl | 126 | 30 |
| Xarelto | Rivaroxaban | 126 | 24 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 119 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 108 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 107 | 38 |
| Alendronate Sodium | Alendronate Sodium | 106 | 30 |
| Metformin Hcl Er | Metformin Hcl | 97 | 27 |
| Ozempic | Semaglutide | 94 | 18 |
| Bupropion Xl | Bupropion Hcl | 92 | 23 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 90 | 23 |
| Sertraline Hcl | Sertraline Hcl | 87 | 23 |
| Finasteride | Finasteride | 86 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 86 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 83 | 53 |
| Ezetimibe | Ezetimibe | 78 | 26 |
| Ondansetron Odt | Ondansetron | 78 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 77 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 74 | 14 |
| Allopurinol | Allopurinol | 73 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 72 | 21 |
| Mirtazapine | Mirtazapine | 69 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 31 |
| Doxycycline Hyclate | Doxycycline Hyclate | 67 | 54 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 65 | 24 |
| Memantine Hcl | Memantine Hcl | 62 | 18 |
| Donepezil Hcl | Donepezil Hcl | 61 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 60 | 21 |
| Valsartan | Valsartan | 57 | 16 |
| Bumetanide | Bumetanide | 56 | 20 |
| Ibuprofen | Ibuprofen | 56 | 16 |
| Solifenacin Succinate | Solifenacin Succinate | 56 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 54 | 13 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 51 | 37 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 49 | 14 |
| Cefuroxime | Cefuroxime Axetil | 46 | 39 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 46 | suppressed |
| Famotidine | Famotidine | 45 | 18 |
| Tradjenta | Linagliptin | 44 | 11 |
| Amoxicillin | Amoxicillin | 43 | 33 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 12 |
| Baclofen | Baclofen | 41 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | 25 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | suppressed |
| Levetiracetam | Levetiracetam | 37 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 36 | suppressed |
| Pregabalin | Pregabalin | 36 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 36 | 14 |
| Verapamil Er | Verapamil Hcl | 36 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | suppressed |
| Spironolactone | Spironolactone | 34 | 14 |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | suppressed |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 32 | suppressed |
| Celecoxib | Celecoxib | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Myrbetriq | Mirabegron | 30 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 29 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 27 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 27 | suppressed |
| Diazepam | Diazepam | 26 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 26 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Fluconazole | Fluconazole | 25 | 15 |
| Meclizine Hcl | Meclizine Hcl | 25 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 18 |
| Klor-Con M10 | Potassium Chloride | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Etodolac | Etodolac | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 21 |
| Naproxen | Naproxen | 22 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 22 | suppressed |
| Temazepam | Temazepam | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Clonazepam | Clonazepam | 21 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Topiramate | Topiramate | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 18 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 18 |
| Repatha Sureclick | Evolocumab | 18 | suppressed |
| Repatha Syringe | Evolocumab | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 17 | suppressed |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Praluent Pen | Alirocumab | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 12 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Neurontin | Gabapentin | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 12 | suppressed |
| Torsemide | Torsemide | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Cartia Xt | Diltiazem Hcl | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Desloratadine | Desloratadine | 11 | suppressed |
| Desoximetasone | Desoximetasone | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Jantoven | Warfarin Sodium | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $114.08 · 4 records | Baxter Healthcare | FREESTYLE LIBRE 3, NURTEC ODT, PAXLOVID, VOQUEZNA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Paxlovid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error